Rebamipide
-
API Product :
Rebamipide
-
CEP :
-
-
WCC :
-
-
Therapeutic Use :
Antacids, antiflatulents and anti-ulcerants
-
Originator :
Otsuka pharmaceutical Co
-
CAS No. :
90098-04-7
-
Trade Name. :
Mucosta , Rebagen , Rebagit
-
Molecular Weight :
370.786 g/mol
-
Molecular Formula :
C19H15ClN2O4
Application
Rebamipide, an amino acid derivative of 2-(1H)-quinolinone, is used for mucosal protection, healing of gastroduodenal ulcers, and treatment of gastritis. It works by enhancing mucosal defense, scavenging free radicals, and temporarily activating genes encoding cyclooxygenase-2.
General Description
Rebamipide, an amino acid derivative of 2-(1H)-quinolinone, is used for mucosal protection, healing of gastroduodenal ulcers, and treatment of gastritis. It works by enhancing mucosal defense, scavenging free radicals, and temporarily activating genes encoding cyclooxygenase-2. Rebamipide is used in a number of Asian countries including Japan (marketed as Mucosta), South Korea, China[1] and India (where it is marketed under the trade name Rebagen). It is also approved in Russia under the brand name Rebagit.[2] It is not approved by the Food and Drug Administration for use in the United States.